Tumor promoters inhibit spontaneous differentiation of Friend erythroleukemia cells in culture.
AUTOR(ES)
Rovera, G
RESUMO
Clones of Friend erythroleukemia cells, characterized by the presence of 40-70% benzidine-positive cells synthesizing hemoglobin in the absence of inducing drugs, were treated with several phorbol diesters with a known range of tumor-promoting activity on mouse skin. Good correlation was found between the reported tumor-promoting activity of a particular phorbol diester and its ability to inhibit spontaneous erythroid differentiation in culture. The inhibition of differentiation by 12-O-tetradecanoyl-phorbol-13-acetate, the most active tumor promoter, was maximum after 4 days of treatment; this inhibition was reversed by removal of the phorbol diester no matter how long the period of treatment. Unlike control cells, which gradually revert to a population with a low percentage of benzidine-positive cells, cells treated with 12-O-tetradecanoyl-phorbol-13-acetate retained a high potential for spontaneous differentiation.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=431336Documentos Relacionados
- Tumor promoters inhibit spontaneous and induced differentiation of murine erythroleukemia cells in culture.
- Initial Characterization of a Spontaneous Interferon Secreted During Growth and Differentiation of Friend Erythroleukemia Cells
- Enucleation of differentiated murine erythroleukemia cells in culture.
- Differentiation of Friend erythroleukemia cells induced by benzodiazepines.
- Tumor promoters alter gene expression and protein phosphorylation in avian cells in culture.
